These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15841317)

  • 1. Plasminogen and matrix metalloproteinase activation by enzymatically modified low density lipoproteins in monocytes and smooth muscle cells.
    May AE; Schmidt R; Bülbül BO; Hölderle M; Walther F; Schömig A; Gawaz M; Klouche M
    Thromb Haemost; 2005 Apr; 93(4):710-5. PubMed ID: 15841317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
    Schmidt R; Redecke V; Breitfeld Y; Wantia N; Miethke T; Massberg S; Fischel S; Neumann FJ; Schömig A; May AE
    Thromb Haemost; 2006 Jan; 95(1):151-8. PubMed ID: 16543974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.
    Schmidt R; Bültmann A; Ungerer M; Joghetaei N; Bülbül O; Thieme S; Chavakis T; Toole BP; Gawaz M; Schömig A; May AE
    Circulation; 2006 Feb; 113(6):834-41. PubMed ID: 16461815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis.
    Torzewski M; Suriyaphol P; Paprotka K; Spath L; Ochsenhirt V; Schmitt A; Han SR; Husmann M; Gerl VB; Bhakdi S; Lackner KJ
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2130-6. PubMed ID: 15345515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells.
    Oak MH; El Bedoui J; Anglard P; Schini-Kerth VB
    Circulation; 2004 Sep; 110(13):1861-7. PubMed ID: 15364805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators.
    Rajavashisth TB; Xu XP; Jovinge S; Meisel S; Xu XO; Chai NN; Fishbein MC; Kaul S; Cercek B; Sharifi B; Shah PK
    Circulation; 1999 Jun; 99(24):3103-9. PubMed ID: 10377072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular smooth muscle cells efficiently activate a new proteinase cascade involving plasminogen and fibronectin.
    Houard X; Monnot C; Dive V; Corvol P; Pagano M
    J Cell Biochem; 2003 Apr; 88(6):1188-201. PubMed ID: 12647301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized low-density and high-density lipoproteins regulate the production of matrix metalloproteinase-1 and -9 by activated monocytes.
    Ardans JA; Economou AP; Martinson JM; Zhou M; Wahl LM
    J Leukoc Biol; 2002 Jun; 71(6):1012-8. PubMed ID: 12050187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic enhancement of cytokine-induced human monocyte matrix metalloproteinase-1 by C-reactive protein and oxidized LDL through differential regulation of monocyte chemotactic protein-1 and prostaglandin E2.
    Zhang Y; Wahl LM
    J Leukoc Biol; 2006 Jan; 79(1):105-13. PubMed ID: 16244112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Native and minimally oxidized low density lipoprotein depress smooth muscle matrix metalloproteinase levels.
    Wilson D; Massaeli H; Pierce GN; Zahradka P
    Mol Cell Biochem; 2003 Jul; 249(1-2):141-9. PubMed ID: 12956409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.
    Augé N; Maupas-Schwalm F; Elbaz M; Thiers JC; Waysbort A; Itohara S; Krell HW; Salvayre R; Nègre-Salvayre A
    Circulation; 2004 Aug; 110(5):571-8. PubMed ID: 15277330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor pathway inhibitor-2 is downregulated by ox-LDL and inhibits ox-LDL induced vascular smooth muscle cells proliferation and migration.
    Zhao B; Luo X; Shi H; Ma D
    Thromb Res; 2011 Aug; 128(2):179-85. PubMed ID: 21458846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis.
    Stawowy P; Meyborg H; Stibenz D; Borges Pereira Stawowy N; Roser M; Thanabalasingam U; Veinot JP; Chrétien M; Seidah NG; Fleck E; Graf K
    Circulation; 2005 May; 111(21):2820-7. PubMed ID: 15911696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UPA promotes lipid-loaded vascular smooth muscle cell migration through LRP-1.
    Lugano R; Peña E; Casani L; Badimon L; Padró T
    Cardiovasc Res; 2013 Nov; 100(2):262-71. PubMed ID: 23812296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes.
    Schmidt R; Bültmann A; Fischel S; Gillitzer A; Cullen P; Walch A; Jost P; Ungerer M; Tolley ND; Lindemann S; Gawaz M; Schömig A; May AE
    Circ Res; 2008 Feb; 102(3):302-9. PubMed ID: 18048771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An MT1-MMP-PDGF receptor-beta axis regulates mural cell investment of the microvasculature.
    Lehti K; Allen E; Birkedal-Hansen H; Holmbeck K; Miyake Y; Chun TH; Weiss SJ
    Genes Dev; 2005 Apr; 19(8):979-91. PubMed ID: 15805464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of PAF receptor by oxidised LDL in human monocytes stimulates chemokine releases but not urokinase-type plasminogen activator expression.
    Beaudeux JL; Said T; Ninio E; Ganné F; Soria J; Delattre J; Soria C; Legrand A; Peynet J
    Clin Chim Acta; 2004 Jun; 344(1-2):163-71. PubMed ID: 15149885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized low-density lipoproteins stimulate extracellular matrix metalloproteinase Inducer (EMMPRIN) release by coronary smooth muscle cells.
    Haug C; Lenz C; Díaz F; Bachem MG
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1823-9. PubMed ID: 15319264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture.
    Shah PK; Falk E; Badimon JJ; Fernandez-Ortiz A; Mailhac A; Villareal-Levy G; Fallon JT; Regnstrom J; Fuster V
    Circulation; 1995 Sep; 92(6):1565-9. PubMed ID: 7664441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological regulation of MMPs and tPA/PAI in the arterial wall of rats by noradrenergic tone and angiotensin II.
    Dab H; Hachani R; Dhaouadi N; Hodroj W; Sakly M; Randon J; Bricca G; Kacem K
    J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):36-45. PubMed ID: 22071631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.